Disclosures for "Cerebrospinal Fluid Testing for Neuroinvasive West Nile Virus and Measures to Improve Guideline Adherence"
-
Dr. Quinn has nothing to disclose.
-
Ms. Singh has nothing to disclose.
-
Mr. Singh has nothing to disclose.
-
An immediate family member of Sarah Turbett has received personal compensation for serving as an employee of Analysis Group Inc. Sarah Turbett has received personal compensation in the range of $0-$499 for serving as a Consultant for CarbX. Sarah Turbett has received research support from SeLux Diagnostics.
-
The institution of Dr. Kanjilal has received research support from CDC.
-
Dr. Harrold has nothing to disclose.
-
The institution of Dr. Solomon has received research support from SafeLinkZ, LLC. Dr. Solomon has received publishing royalties from a publication relating to health care.
-
Dr. Venna has nothing to disclose.
-
Dr. Pastula has nothing to disclose.
-
The institution of Dr. Chauhan has received research support from NIH. The institution of an immediate family member of Dr. Chauhan has received research support from University of Colorado.
-
Dr. Klontz has nothing to disclose.
-
Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.